Target Price | $61.36 |
Price | $55.12 |
Potential |
11.33%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target W. P. Carey Inc. 2025 .
The average W. P. Carey Inc. target price is $61.36.
This is
11.33%
register free of charge
$70.00
27.00%
register free of charge
$56.00
1.60%
register free of charge
|
|
A rating was issued by 14 analysts: 2 Analysts recommend W. P. Carey Inc. to buy, 10 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the W. P. Carey Inc. stock has an average upside potential 2025 of
11.33%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 1.74 | 1.51 |
17.73% | 13.16% | |
EBITDA Margin | 79.13% | 86.67% |
9.31% | 9.53% | |
Net Margin | 41.22% | 69.32% |
6.82% | 68.16% |
11 Analysts have issued a sales forecast W. P. Carey Inc. 2024 . The average W. P. Carey Inc. sales estimate is
This results in the following potential growth metrics:
9 Analysts have issued an W. P. Carey Inc. EBITDA forecast 2024. The average W. P. Carey Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.28 | 4.79 |
9.70% | 46.04% | |
P/E | 11.51 | |
EV/Sales | 12.80 |
Based on analysts' sales estimates for 2024, the W. P. Carey Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
W. P. Carey Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.